Xontogeny

News

Perceptive Advisors Closes Inaugural $210 Million Perceptive Xontogeny Venture Fund to Support Early-Stage Biotech Startups

Quellis Biosciences Inc. Announces $17 Million Series A Financing

Landos Biopharma Completes $60 Million Series B Financing

Landos Biopharma Raises $10 Million in Series A Financing

Xontogeny Appoints Industry Veteran Fred Callori as Senior Vice President of Corporate Development

Xontogeny, a New Accelerator Operating Company, Launches with a $25 Million Series A Financing to Advance Early Stage Life Sciences Technology through Clinical Proof-of-Concept

Privacy Preference Center

Advertising

The NID, DSID, IDE cookies are set by DoubleClick (which is owned by Google) to help build a profile of your interests and show you relevant ads on other sites. The other cookies (from google.com) carry out information about how the end user uses the website and any advertising that the end user may have seen before visiting the said website.

NID, IDE, 1P_JAR, AID, ANID, APISID, DSID, DV, HSID, SAPISID, SID, SIDCC, SSID

Analytics

Xontogeny uses these cookies to collect information about how visitors use our Site. We use the information to compile reports and to help us improve the Site. The cookies collect information in an anonymous form, including the number of visitors to the Site, where visitors have come to the Site from and the pages they visited. If you do not allow these cookies we will not be able to include your visit in our statistics. You can read the full Google Analytics privacy policy at: http://www.google.com/policies/privacy/.

_ga,_gat,_gid, _gali

Functionality

The OGPC cookie enables the functionality of Google Maps. s_cc Adobe Site Catalyst cookie, determines whether cookies are enabled in the browser. The s_sq and s_vi, Adobe Site Catalyst cookie, stores information about the previous link clicked within the site as well as identify unique visitors, with an ID and timestamp.

OGPC, s_cc, s_sq, s_vi